# Diadexus, Inc.

Diadexus, Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** Diadexus, Inc.
- **Former names in filing history:** VAXGEN INC (1999-07-13 to 2010-10-12)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001036968

## About

Diadexus, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001036968, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-29, it reported annual revenue of USD 18,114,000; net income of USD -7,166,000; total assets of USD 13,155,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $18.1M (USD 18,114,000)
- **Net income:** -$7.2M (USD -7,166,000)
- **Total assets:** $13.2M (USD 13,155,000)
- **Cash and equivalents:** $9.1M (USD 9,116,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $26.4M (USD 26,423,000)
- **Net income:** -$8.5M (USD -8,467,000)
- **Total assets:** $22.3M (USD 22,293,000)
- **Cash and equivalents:** $14.9M (USD 14,946,000)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $24.9M (USD 24,884,000)
- **Net income:** -$2.2M (USD -2,164,000)
- **Total assets:** $23.6M (USD 23,647,000)
- **Cash and equivalents:** $16.8M (USD 16,847,000)
- **Operating cash flow:** -$2.1M (USD -2,094,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $20.8M (USD 20,776,000)
- **Net income:** -$2.8M (USD -2,789,000)
- **Total assets:** $20.5M (USD 20,484,000)
- **Cash and equivalents:** $12.9M (USD 12,851,000)
- **Operating cash flow:** -$3.4M (USD -3,443,000)

## Recent SEC filings

- Form SC 13G — filed 2017-02-13 — MSSB 13G NO 359
- Form 10-Q — filed 2016-04-29 — period 2016-03-31 — 10-Q
- Form 8-K — filed 2016-04-29 — period 2016-04-28 — 8-K
- Form 8-K — filed 2016-04-18 — period 2016-04-18 — 8-K
- Form 8-K — filed 2016-04-01 — period 2016-03-31 — 8-K
- Form 10-K — filed 2016-03-29 — period 2015-12-31 — 10-K
- Form 8-K — filed 2016-03-29 — period 2016-03-28 — 8-K
- Form SC 13D — filed 2016-03-28 — THE SCHEDULE 13D
- Form 8-K — filed 2016-03-18 — period 2016-03-14 — 8-K
- Form 10-Q — filed 2015-10-30 — period 2015-09-30 — 10-Q
- Form 8-K — filed 2015-10-26 — period 2015-10-26 — 8-K
- Form 8-K — filed 2015-09-08 — period 2015-09-04 — FORM 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/diadexus-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology